Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacquelyn J Maher

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Gastroenterology Reports|March 6, 2007
Alcoholic steatohepatitis: management and prognosisJacquelyn J Maher
Hepatology (Baltimore, Md.)|September 18, 2016
Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile?Jacquelyn J Maher
Gastroenterology|February 27, 2010
Trunk fat as a determinant of liver diseaseJacquelyn J Maher
Seminars in Gastrointestinal Disease|April 12, 2002
Alcoholic steatosis and steatohepatitisJacquelyn J Maher
Hepatology (Baltimore, Md.)|May 25, 2013
Retinol binding protein 4 and fatty liver: A direct link?Jacquelyn J Maher
Antioxidants & Redox Signaling|December 4, 2010
New insights from rodent models of fatty liver diseaseJacquelyn J Maher
The Journal of Clinical Investigation|September 16, 2025
Loss of function of T-box 3 in the liver protects against MASLDJacquelyn J Maher
Nature Medicine|February 3, 2025
Not the end of the road for macrophage therapy in liver cirrhosisJacquelyn J Maher
Hepatology (Baltimore, Md.)|April 2, 2004
What doesn't kill you makes you stronger: how hepatocytes survive prolonged cholestasisJacquelyn J Maher
The Journal of Clinical Investigation|February 27, 2009
DAMPs ramp up drug toxicityJacquelyn J Maher
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Gastroenterology Reports|March 6, 2007
Alcoholic steatohepatitis: management and prognosisJacquelyn J Maher
Hepatology (Baltimore, Md.)|September 18, 2016
Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile?Jacquelyn J Maher
Gastroenterology|February 27, 2010
Trunk fat as a determinant of liver diseaseJacquelyn J Maher
Seminars in Gastrointestinal Disease|April 12, 2002
Alcoholic steatosis and steatohepatitisJacquelyn J Maher
Hepatology (Baltimore, Md.)|May 25, 2013
Retinol binding protein 4 and fatty liver: A direct link?Jacquelyn J Maher
Antioxidants & Redox Signaling|December 4, 2010
New insights from rodent models of fatty liver diseaseJacquelyn J Maher
The Journal of Clinical Investigation|September 16, 2025
Loss of function of T-box 3 in the liver protects against MASLDJacquelyn J Maher
Nature Medicine|February 3, 2025
Not the end of the road for macrophage therapy in liver cirrhosisJacquelyn J Maher
Hepatology (Baltimore, Md.)|April 2, 2004
What doesn't kill you makes you stronger: how hepatocytes survive prolonged cholestasisJacquelyn J Maher
The Journal of Clinical Investigation|February 27, 2009
DAMPs ramp up drug toxicityJacquelyn J Maher
Pageof 8